BioMarin Pharmaceutical | BMRN - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 10.08 1.53 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Amgen 19.84 5.47 2026-03
Bayer 3.4 8.75 2026-03
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Gilead Sciences 17.7 2.07 2026-03
Incyte 15.35 0.51 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 28.09 807.38 2026-03
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Roche Holding 16.09 3.51 2025-12
Sanofi 15.75 1.53 2025-12
Sarepta Therapeutics 27.27 0 2025-12
United Therapeutics 20.42 3.1 2026-03
Vertex Pharmaceuticals 25.82 0.33 2026-03